Mayinglong Care

Mayinglong Care is the English-language name supplied for the commercial entity 马应龙护理. The available official material identifies Mayinglong primarily as Mayinglong Pharmaceutical Group Co., Ltd. and describes a range of healthcare, medicine and health-product activities. It does not separately establish a company, launch date or complete product catalogue specifically under the name “Mayinglong Care”; accordingly, the dossier treats it as a brand identity associated with the group rather than as an independently verified operating company. The group traces its origins to 1582, when its official brand history says Ma Jintang founded an eye-medicine business in Dingzhou. Its original eye-care heritage has broadened over time. The company describes product areas including anorectal health, ophthalmic care and skin health, alongside pharmaceutical manufacturing, pharmaceutical commerce, clinical services and broader health products. It names Mayinglong Musk Hemorrhoid Ointment, Musk Hemorrhoid Suppositories, Mayinglong Babao Eye Ointment and Longzhu Ointment among its distinctive medicines, and reports developing functional eye creams and other health products. Mayinglong Pharmaceutical Group is headquartered in Wuhan, Hubei, and is listed on the Shanghai Stock Exchange under 600993.SH. Its official homepage describes it as an enterprise under China Baoan Group. The company presents its approach as combining inheritance of traditional formulations and brand heritage with product development and expansion into related healthcare services. Official materials also position it as a provider of anorectal-health solutions and describe expansion in eye-care and skin-health care. The supplied evidence does not establish a separate founding date, founder, executive roster or dedicated corporate structure for Mayinglong Care. The group’s 1582 origin and historical founder therefore describe the wider Mayinglong heritage, not a proven launch date or founder for this specific care identity.

The evidence supplied for Mayinglong Care is principally corporate and brand information about Mayinglong Pharmaceutical Group, rather than a dedicated history of a separately documented Mayinglong Care business. The group’s official history traces the Mayinglong eye-medicine tradition to 1582, during the Ming dynasty. It names Ma Jintang as the originator of the early Dingzhou eye medicine. The official account says his successor Ma Yinglong developed and sold the eye medicine under the Mayinglong name, establishing a commercial identity around the product. According to the company’s brand-history account, descendants carried the business beyond its original locality. Ma Wanxing travelled to Beijing during the Daoguang era to establish a shop, and the business later extended south. In 1919, Ma Qishan moved to Wuhan and opened a shop in Wuchang. The official history also recounts disruption during the 1922 upheaval in Wuhan. These events belong to the wider Mayinglong brand history; the evidence does not connect them to a separately named Mayinglong Care brand. The modern corporate group says it has operated continuously for more than four centuries and reports that it underwent shareholding-system reform in 1995. The group states that it restored the Mayinglong trade name in 1995, renewed its brand-development strategy, and developed beyond its original eye-medicine base. Over time its portfolio came to include anorectal medicines such as Mayinglong Musk Hemorrhoid Ointment and Musk Hemorrhoid Suppositories, the skin medicine Longzhu Ointment, eye-care products and broader health products. The company describes a strategic focus on anorectal health and subsequent extension into clinical services and related health activities. The official company profile says that the traditional eye-medicine preparation technique was recognized as a national-level intangible cultural heritage in 2011. Official brand news identifies Mayinglong Babao as an eye-care brand established in 2009 and says Mayinglong Pharmaceutical’s first functional cosmetic was Mayinglong Babao Eye Cream. The group also describes further development of eye-care and skin-health-care activities. The company identifies itself as Mayinglong Pharmaceutical Group Co., Ltd. (600993.SH), headquartered in Wuhan, and the homepage describes it as an enterprise under China Baoan Group. The supplied material gives no separately attributable founding date, ownership structure, leadership team or complete product list for the exact name Mayinglong Care. Its history should therefore be understood through the documented group and associated product brands, without treating the care name as a separately proven legal entity.

• 2024

  Clinical-application expert consensus for Longzhu Ointment issued

• 2011

  Traditional eye-medicine preparation technique recognized as intangible cultural heritage

• 2009

  Mayinglong Babao eye-care brand introduced

• 1995

  Shareholding reform and renewed brand operations

• 1919

  The business moves south to Wuhan

• 1582

  Mayinglong eye-medicine tradition begins

Associated with a heritage Chinese pharmaceutical group extending traditional medicine and healthcare expertise into eye care, skin health, anorectal health and broader health products. The evidence does not establish a distinct positioning statement specifically for Mayinglong Care.

• Mayinglong Babao Eye Ointment

  An eye-care medicine associated with the group's historical eye-medicine business.

• Mayinglong Musk Hemorrhoid Ointment

  A named medicine in the group's anorectal-health range.

• Musk Hemorrhoid Suppositories

  A named anorectal medicine in the company's portfolio.

• Longzhu Ointment

  A skin medicine for which the official site reports a clinical-application expert consensus.

• Mayinglong Babao Eye Cream

  The group identifies it as its first functional cosmetic, launched in 2009.

• Counterfeit 'Mayinglong Musk Hemorrhoid Ointment' products sold online

  Source

Read more

• “P da dian shi, guanhu jian kang da shi” public-welfare marketing project
• National co-development of anorectal specialty departments

• Strategic transition from medicine manufacturing toward anorectal-health solutionsOther

1. 1马应龙药业集团-官网首页-股票代号：600993.SHmayinglong.cn
2. 2品牌故事-马应龙集团mayinglong.cn
3. 3品牌资讯-马应龙集团mayinglong.cn
4. 4公司简介-马应龙集团mayinglong.cn